Lipophilicity of beta blockers.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D002493:Central Nervous System Diseases / Q000139:chemically induced; D006801:Humans; D012995:Solubility; D013999:Timolol / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D013999:Timolol